Q4 FY2026 Earnings
Financial report interval: 2026.01.30 - 2026.04.30
Overview: PharmaCyte Biotech(PMCB) the EBIT is -961.83 K (+7.68%);the EPS is -0.457 (-128.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B7.68%
----
----
EPS
-0.4572128.90%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf